Sorafenibtosylate for the treatment of diseases characterized by abnormal angiogenesis

• 收藏
• 分享

专利权人:

BAYER HEALTHCARE LLC

发明人:

DUMAS, JACQUES,SCOTT, WILLIAM, J.,ELTING, JAMES,HATOUM-MAKDAD, HOLIA

申请号：

DK03707846

公开号：

DK1478358T3

申请日:

2003.02.11

申请国别(地区):

DK

年份:

2013

代理人:

摘要：

This invention relates to the use of aryl ureas in the manufacture of a medicament for treating or preventing diseases characterized by abnormal angiogenesis or hyperpermeability processes which are mediated by the VEGF induced signal transduction pathway.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/